# IMIPENEM AND CILASTATIN
> **ANDA091007** · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA INC · Approved 2011-11-16
## Drug
- **FDA Application Number:** ANDA091007
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IMIPENEM AND CILASTATIN
- **Generic name:** Cilastatin Sodium
- **Active ingredients:** CILASTATIN SODIUM; IMIPENEM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** HOSPIRA INC
- **First approval:** 2011-11-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091007)
---
*AI Analytics · CC0 1.0*